These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 12080440

  • 1. Obesity and the polycystic ovary syndrome.
    Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R.
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 5. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK, Mário FM, Alves BC, Spritzer PM.
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovary syndrome.
    Goudas VT, Dumesic DA.
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [Abstract] [Full Text] [Related]

  • 7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 8. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
    Rittmaster RS, Deshwal N, Lehman L.
    J Clin Endocrinol Metab; 1993 May; 76(5):1295-300. PubMed ID: 8388405
    [Abstract] [Full Text] [Related]

  • 9. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE.
    Treat Endocrinol; 2006 May; 5(3):171-87. PubMed ID: 16677059
    [Abstract] [Full Text] [Related]

  • 10. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 12. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
    Giudice LC.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
    [Abstract] [Full Text] [Related]

  • 13. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 14. [Influence of weight and distribution of adipose tissue in functional hyperandrogenism].
    Pasquali R, Vicennati V, Gambineri A.
    Contracept Fertil Sex; 1998 May; 26(5):372-5. PubMed ID: 9648381
    [Abstract] [Full Text] [Related]

  • 15. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 16. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A, Pagotto U.
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Tolino A, Gambardella V, Caccavale C, D'Ettore A, Giannotti F, D'Antò V, De Falco CL.
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar 01; 119(1):87-93. PubMed ID: 15734091
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R, Cohen PR.
    Med Hypotheses; 2007 Mar 01; 68(3):480-3. PubMed ID: 17134841
    [Abstract] [Full Text] [Related]

  • 19. The polycystic ovary syndrome.
    Reyniak JV.
    J Reprod Med; 1983 Apr 01; 28(4):245-50. PubMed ID: 6683320
    [Abstract] [Full Text] [Related]

  • 20. Changes in the PCOS phenotype with age.
    Hsu MI.
    Steroids; 2013 Aug 01; 78(8):761-6. PubMed ID: 23624031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.